Cargando…
Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy
Liver diseases have become a major comorbidity health concern for people living with HIV-1 (PLWH) treated with combination antiretroviral therapy (cART). To investigate if HIV-1 infection and cART interact to lead to liver diseases, humanized mice reconstituted with progenitor cells from human fetal...
Autores principales: | Ahodantin, James, Nio, Kouki, Funaki, Masaya, Zhai, Xuguang, Wilson, Eleanor, Kottilil, Shyamasundaran, Cheng, Liang, Li, Guangming, Su, Lishan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310524/ https://www.ncbi.nlm.nih.gov/pubmed/35639478 http://dx.doi.org/10.1172/jci.insight.152738 |
Ejemplares similares
-
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
por: Mathur, Poonam, et al.
Publicado: (2018) -
Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus
por: Khanam, Arshi, et al.
Publicado: (2020) -
Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection
por: Husson, Jennifer S., et al.
Publicado: (2017) -
The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis
por: Mallikarjuna, Pramod, et al.
Publicado: (2022) -
Immunomodulatory therapies for COVID-19
por: Mathur, Poonam, et al.
Publicado: (2022)